(Peg)interferon ((Peg)IFN) therapy leads to response in a minority of chronic hepatitis B (CHB) patients. Host genetic determinants of response are therefore in demand.
Brouwer, W.P., Chan, H.L., Lampertico, P., Hou, J., Tangkijvanich, P., Reesink, H.W., et al. (2019). Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study. CLINICAL INFECTIOUS DISEASES [10.1093/cid/ciz084].
Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study
Montalto, Giuseppe;
2019-01-01
Abstract
(Peg)interferon ((Peg)IFN) therapy leads to response in a minority of chronic hepatitis B (CHB) patients. Host genetic determinants of response are therefore in demand.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Giant-B.pdf
accesso aperto
Tipologia:
Post-print
Dimensione
966.52 kB
Formato
Adobe PDF
|
966.52 kB | Adobe PDF | Visualizza/Apri |
|
ciz084.pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
7.83 MB
Formato
Adobe PDF
|
7.83 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
